Details of the Probe-central Interaction Altas
General Information of Experiment
Probe Name | Alkyne-RA190 | Probe Info | ||||
---|---|---|---|---|---|---|
Probe concentration | 30 uM | |||||
Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
Quantitative Method |
LFQ
|
|||||
Competitor Name | RA190 | Competitor Info | ||||
Competitor Concentration | 30 uM | |||||
In Vivo Experiment Model | Model Type |
|
Living cell | |||
Derived Tissue |
|
Skin | ||||
Disease Model | Cutaneous melanoma [ICD-11:2B00] | |||||
Model Name | Human cutaneous melanoma cells (SK-MEL-5) | |||||
Interaction Altas of This Experiment [1]
Enzyme
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP09841 | Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (ALG3) | 35.0 | ||||
LDTP03599 | Dimethylaniline monooxygenase [N-oxide-forming] 4 (FMO4) | 31.3 | ||||
LDTP18083 | Probable N-acetyltransferase 14 (NAT14) | 28.0 | ||||
LDTP13367 | Glutathione hydrolase 7 (GGT7) | 16.4 | ||||
LDTP09620 | Soluble calcium-activated nucleotidase 1 (CANT1) | 7.1 | ||||
LDTP07813 | Sulfhydryl oxidase 2 (QSOX2) | 5.1 | ||||
LDTP17587 | Catechol O-methyltransferase domain-containing protein 1 (COMTD1) | 4.4 | ||||
LDTP03676 | ATP-binding cassette sub-family D member 1 (ABCD1) | 3.8 | ||||
LDTP07323 | Acyl-coenzyme A thioesterase MBLAC2 (MBLAC2) | 3.6 | ||||
LDTP10038 | Mitochondrial ubiquitin ligase activator of NFKB 1 (MUL1) | 3.6 | ||||
LDTP01065 | E3 ubiquitin-protein ligase TRIM13 (TRIM13) | 3.4 | ||||
LDTP11127 | ADP-dependent glucokinase (ADPGK) | 3.0 | ||||
LDTP19892 | DGAT1/2-independent enzyme synthesizing storage lipids (TMEM68) | 2.7 | ||||
LDTP00598 | Serine palmitoyltransferase 2 (SPTLC2) | 2.4 | ||||
LDTP01219 | NADH dehydrogenase 1 beta subcomplex subunit 1 (NDUFB1) | 2.2 | ||||
LDTP09060 | Ubiquitin-associated domain-containing protein 2 (UBAC2) | 2.1 | ||||
LDTP12057 | ATPase PAAT (PAAT) | 2.1 | ||||
LDTP04303 | Presenilin-1 (PSEN1) | 2.1 |
Transporter and channel
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP09502 | Nuclear pore membrane glycoprotein 210 (NUP210) | 30.3 | ||||
LDTP14952 | Mpv17-like protein 2 (MPV17L2) | 7.1 | ||||
LDTP06490 | Vesicle-associated membrane protein 3 (VAMP3) | 5.9 | ||||
LDTP05875 | Transmembrane emp24 domain-containing protein 1 (TMED1) | 2.6 |
Transcription factor
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP06495 | Upstream stimulatory factor 2 (USF2) | 2.9 | ||||
LDTP00351 | Class E basic helix-loop-helix protein 40 (BHLHE40) | 2.1 |
Other
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP15599 | UPF0729 protein C18orf32 (C18orf32) | 132.4 | ||||
LDTP19425 | Uncharacterized protein C12orf60 (C12orf60) | 24.7 | ||||
LDTP13664 | Syntaxin-8 (STX8) | 5.0 | ||||
LDTP12755 | OCIA domain-containing protein 1 (OCIAD1) | 2.8 | ||||
LDTP15110 | Protein C3orf33 (C3orf33) | 2.7 | ||||
LDTP16142 | BET1-like protein (BET1L) | 2.6 | ||||
LDTP05257 | Receptor expression-enhancing protein 5 (REEP5) | 2.5 | ||||
LDTP15973 | Melanoma-associated antigen H1 (MAGEH1) | 2.5 | ||||
LDTP18863 | Uncharacterized protein C15orf61 (C15orf61) | 2.5 | ||||
LDTP08902 | CDGSH iron-sulfur domain-containing protein 2 (CISD2) | 2.3 | ||||
LDTP00632 | Syntaxin-7 (STX7) | 2.2 |